  - Elan-Cambridge partnership will research neurological drugs
Elan and Cambridge University have agreed to establish a center to discover therapies for neurodegenerative diseases, including Parkinson's and Alzheimer's. The biotech company will invest $10 million during the next five years and can extend the collaboration to 10 years. Reuters (11/27)        | Download the latest Spotlight On… Melanoma report
This quarter’s Spotlight On… report focuses on Melanoma, which is currently experiencing an innovation breakthrough. The Spotlight On... report draws on the expert insight and strategic data from Thomson Reuters Pharma – the world's leading competitive intelligence solution. Download today. |
 - GVK forms biomarker-discovery alliance with Temple University
India's GVK Biosciences agreed to work with the Moulder Center for Drug Discovery Research at Temple University to identify small-molecule biomarkers in various therapeutic areas, including the central nervous system. The center was created in 2009 to promote collaboration among pharmaceutical and biotech firms. MedCityNews.com (11/28) - Hospital is designed to handle pandemic, bioterrorist attack
Rush University Medical Center in Chicago has designed an emergency room that is intended to handle pandemic diseases and bioterrorist attacks. The ER features 60 treatment bays to accommodate and decontaminate more than the usual number of patients and includes fixtures for the isolation of patients. Chicago Tribune (11/30) - Gene screening helps identify aggressive prostate cancers
U.S. researchers reported that they have identified two aggressive subtypes of prostate cancer using genetic tests of prostate tumor tissues. The cancer subtypes, which were found to increase death risk by 3.2 times, could be used to aid the Gleason method for predicting prostate cancer if the study results are validated in larger trials. Bloomberg (11/28)  | The telephony market is making a lot of smart people make poor choices. Take a minute to read the latest VoIP News and ground your opinion in hard-bitten analysis. In this complimentary guide, we chart the future of IP-convergence, mobility, IPv6, and much more. Get the VoIP News here. |
 - Onyx shares rise on reports it is exploring options
Onyx Pharmaceuticals' stock price rose as sources said the biopharmaceutical firm is reviewing strategic alternatives, including the possibility of a sale of the company. Last month, Onyx ended a dispute with Bayer regarding cancer drug candidate regorafenib, and the companies amended a partnership for kidney cancer medicine Nexavar. Bloomberg (11/29)  | Developing Improved, Safer Processes
This webinar describes how reaction calorimetry is used to develop improved scalable processes. Process development methods to manage delayed initiation or uncontrolled exotherm are explained using real case studies at Johnson and Johnson. Register for the webinar here. |
 - Poll: The commissioner of the FDA has said the agency must advance regulatory science and be a catalyst for innovation. In 2012, what do you expect?
View the results of this poll in the BIO SmartBrief Best Of 2011 special report on Dec. 14.  | The push to streamline regulation will bring faster approvals and clearances | | Improvement will come, but it will take longer than a year | | The changes will be incremental and ineffective | | The push to streamline regulation will instead make the process more difficult | | Investment and innovation will be greater in unregulated fields of the life sciences |
 | Only in North Carolina can you find so many unique innovations to help heal, fuel AND feed the world. Discover NC’s complete package and why 538 companies call NC home. | - India, U.K. collaborate on bioenergy research
India's Department of Biotechnology has entered into a collaborative research deal with the U.K. Biotechnology and Biological Sciences Research Council on producing energy from sources such as plants and algae. The approximately $15.5 million bioenergy project will be jointly funded by the agencies and is intended to "help both nations develop sustainable alternatives to fossil fuels," said David Willetts, U.K. minister for universities and science. ZME Science (11/28) - Cuba, China to cooperate in biotech-related efforts
Cuba and China have entered into an agreement to promote continued cooperation between the two countries in the biotech field, with a focus on biomedicine and agriculture. The countries aim to consolidate joint venture efforts and establish joint research centers. Cuba Headlines (11/28)  | Tokenization is more than a security measure and more than a cost savings technique. It can be used to build your business. This white paper discusses the ways tokens can be used in back-end business operations to develop powerful marketing programs. |
| Food & Agriculture |  |  | | - France overturns ban on Monsanto biotech maize
The highest French court has scrapped a nationwide moratorium on the cultivation of Monsanto's insect-resistant MON810 maize. The European Court of Justice previously ruled that France used the wrong European Union legislation in deciding to impose a ban on the biotech crop. "Drawing on the consequences of the ECJ's ruling, the State Council finds that the agriculture ministry could not justify its authority to issue the decrees, failing to give proof of the existence of a particularly high level of risk for the health and the environment," the court ruled. Reuters (11/28)
| Industrial & Environmental | | | | | News from BIO | | | | - BIOtechNOW
BIOtechNOW is the first in a number of new products from BIO intended to enhance our communications with the biotech community -- not only with our members, but with other stakeholders as well. This monthly e-newsletter, combined with its website, serves as our flagship in that effort. BIOtechNOW will offer original content that emphasizes the business needs of the industry; highlight BIO's advocacy efforts; and provide a portal to all BIO activities and events. Most importantly, it will spotlight for those outside the industry the value of biotechnology. Sign up for the monthly BIOtechNOW e-newsletter.
| SmartQuote | | | |  | We have always found that people are most productive in small teams with tight budgets, time lines and the freedom to solve their own problems."
--John Rollwagen,
American corporate executive  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Monday, November 28, 2011
- Wednesday, November 23, 2011
- Tuesday, November 22, 2011
- Monday, November 21, 2011
- Friday, November 18, 2011
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2011 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment